Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

Petra J. Woestenberg, Audrey J. King, Birgit H. B. van Benthem, Robine Donken, Suzan Leussink, Fiona R. M. van der Klis, Hester E. de Melker, Marianne A. B. van der Sande, Christian J. P. A. Hoebe, Med Microbiological Labs Public, Petra Wolffs, Johannes A. Bogaards

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)213-222
Number of pages10
JournalJournal of Infectious Diseases
Volume217
Issue number2
DOIs
Publication statusPublished - 15 Jan 2018

Keywords

  • human papillomavirus
  • human papillomavirus vaccine
  • vaccine effectiveness
  • public health
  • Cervarix
  • HUMAN-PAPILLOMAVIRUS VACCINATION
  • HPV-16/18 AS04-ADJUVANTED VACCINE
  • INVASIVE CERVICAL-CANCER
  • BLIND PATRICIA TRIAL
  • OF-STUDY ANALYSIS
  • INTRAEPITHELIAL NEOPLASIA
  • BROAD-SPECTRUM
  • PCR ASSAY
  • INFECTION
  • EFFICACY

Cite this

Woestenberg, P. J., King, A. J., van Benthem, B. H. B., Donken, R., Leussink, S., van der Klis, F. R. M., de Melker, H. E., van der Sande, M. A. B., Hoebe, C. J. P. A., Med Microbiological Labs Public, Wolffs, P., & Bogaards, J. A. (2018). Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors. Journal of Infectious Diseases, 217(2), 213-222. https://doi.org/10.1093/infdis/jix582